ANCE - RESTANCE Highlights Hugh Hefner and Playboy's Contribution To Fighting AIDS and Advocating Gay Rights
Sparks, NV -- November 29, 2017 -- InvestorsHub
NewsWire -- RESTANCE, Inc. (USOTC: ANCE)
recently announced winning a contract to manufacture Playboy brand
name condoms for distribution in in Africa, starting in Kenya as
part of a the #DoIt4Africa
buy-one-give-one campaign where an anticipated $20 million in
condoms will be sold in North American and for every condom sold, a
condom will be manufactured in Africa and given away in
Africa. The contract was announced in conjunction with World
AIDS Day which takes place tomorrow, December 1, 2017.
RESTANCE is participating in the #DoIt4Africa
campaign to contribute to the United Nations goal of ending the
AIDS Epidemic.
Hefner and Playboy Ahead Of Their Time In
Fighting AIDS and Advocating Gay Rights
In conjunction with World AIDS Day, RESTANCE is
paying tribute to Hugh Hefner and Playboy’s role in the fight
against AIDS and support of Gay Rights. Hefner and Playboy
are on record as early as 1955 in support of Gay Rights. When
AIDS was being dismissed as a “gay plague,” Playboy discussed it as
a wider concern and advocated for safer sex. Hefner said,
“The only thing “wrong” with AIDS is the way our government
responded to it. They are culpable on many, many
levels.”
Learn more about Playboy and Hefner’s role in
fightin AIDS in Advocating for Gay Rights in the recent
article:
This is what Playboy founder Hugh
Hefner thought about AIDS and
gay rights
In addition to opening a condom manufacturing
plant, RESTANCE is pursuing several other business lines in the
growing economies of East Africa. The Company is developing
opportunities in the region including initiatives in technology and
systems integration services, utility support services, affordable
housing and health products manufacturing. RESTANCE recently
acquired East African Development Partners as part of its strategy
in East Africa.
Learn more about the RESTANCE operations in
Africa on the Company's website: www.restanceinc.com
Other OTC quoted companies with services
addressing the AIDS epidemic include DanDrit Biotech (DDRT), Immune
Therapeutics (IMUN) and Progressive Care (RXMD).
Disclaimer/Safe Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not
occur.
Randell Torno
ir@restanceinc.com
+1-800-834-5792
Restance (CE) (USOTC:ANCE)
過去 株価チャート
から 10 2024 まで 11 2024
Restance (CE) (USOTC:ANCE)
過去 株価チャート
から 11 2023 まで 11 2024
Real-Time news about Restance Inc (CE) (その他OTC): 0 recent articles
その他のRestance, Inc. (PC)ニュース記事